Unique ID issued by UMIN | UMIN000008641 |
---|---|
Receipt number | R000010155 |
Scientific Title | Clinical analysis about efficacy of Lipo PGE1 injection for arteriosclerosis obliterans and lumbar spinal canal stenosis merger cases that an oral agent was invalid |
Date of disclosure of the study information | 2012/08/08 |
Last modified on | 2017/02/10 21:26:58 |
Clinical analysis about efficacy of Lipo PGE1 injection for arteriosclerosis obliterans and lumbar spinal canal stenosis merger cases that an oral agent was invalid
Clinical analysis about the efficacy of Lipo PGE1 injection for arteriosclerosis obliterans and lumbar spinal canal stenosis merger cases
Clinical analysis about efficacy of Lipo PGE1 injection for arteriosclerosis obliterans and lumbar spinal canal stenosis merger cases that an oral agent was invalid
Clinical analysis about the efficacy of Lipo PGE1 injection for arteriosclerosis obliterans and lumbar spinal canal stenosis merger cases
Japan |
arteriosclerosis obliterans
lumbar spinal canal stenosis
Orthopedics |
Others
NO
To examine efficacy of the Lipo PGE1 injection for arteriosclerosis obliterans and lumbar spinal canal stenosis that an oral agent was invalid
Efficacy
VAS of the pain of lower extremities
JOA score
JOABPEQ score
Observational
20 | years-old | <= |
90 | years-old | > |
Male and Female
The patients who meet all the following criteria for selection.
(1), 20 years old or older, is the patients for all sex.
(2) The patients who had diagnosis of lumbal spinal canal stenosis by a diagnosis support tool and MRI.
(3) The patients who had diagnosis of arteriosclerosis obliterans with API (<1.0) or TB I (<= 0.6).
(4) The patients whom improvement of the VAS (visual analogue scale) score of the pain of lower extremities was not seen in even if took an oral agent (LSCS therapeutic drug, PAD therapeutic drug) more than one month.
(1) The Lipo PGE1 injection administration contraindication patients
patients with serious heart failure
The patients who have bleeding (intracranial bleeding, haemorrhage of digestive tract, hemoptysis)
woman who may be pregnant
patients with hypersensitivity for this medicine
(2) Patients whom a purpose of this study cannot understand
30
1st name | |
Middle name | |
Last name | Tomohiko Hasegawa |
Hamamatsu University School of Medicine
Department of Orthopaedic Surgery
1-20-1, Handayama, Higashi ward, Hamamatsu city, Shizuoka
1st name | |
Middle name | |
Last name |
Hamamatsu University School of Medicine
Department of Orthopaedic Surgery
arihidee@yahoo.co.jp
Hamamatsu University School of Medicine
Self funding
Self funding
NO
2012 | Year | 08 | Month | 08 | Day |
Unpublished
Completed
2012 | Year | 08 | Month | 08 | Day |
2012 | Year | 08 | Month | 08 | Day |
To examine efficacy of the Lipo PGE1 injection for arteriosclerosis obliterans and lumbar spinal canal stenosis that an oral agent was invalid
2012 | Year | 08 | Month | 08 | Day |
2017 | Year | 02 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010155
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |